COMMUNIQUÉS West-GlobeNewswire

Nxera Pharma Operational Highlights and Consolidated Results for the Third Quarter 2026
30/10/2026
Tokyo, Japan and Cambridge, UK, 30 October 202 6 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the third quarter ended 30 [...]
Press Release: Q3 2026: double-digit growth in sales and business EPS FY 2026: guidance upgraded
30/10/2026
Q3 2026: double-digit growth in sales and business EPS FY 2026: guidance upgraded October 30, 2026 Q3 sales growth of 14.3% at CER 1 and business earnings per share (EPS) 2 of €3.55 Pharma launches sales increased by 31 [...]
Communiqué de presse : T3 2026 : croissance à deux chiffres du chiffre d’affaires et du BNPA ; révision à la hausse des perspectives 2026
30/10/2026
T3 2026 : croissance à deux chiffres du chiffre d’affaires et du BNPA ; révision à la hausse des perspectives 2026 Paris, le 30 octobre 2026 Ventes du T3 en progression de 14,3 % à TCC 1 et BNPA 2 des activités de 3,55 [...]
Nicox Reports First Half 2026 Financial Results
30/10/2026
Press Release Nicox Reports First Half 2026 Financial Results Revenue increased to €3.5 million compared to €1.5 million in H1 2025 Net loss decreased to €0.5 million from €8.9 million in H1 2025 Cash and cash [...]
Nicox publie les résultats financiers du premier semestre 2026
30/10/2026
Communiqué de presse Nicox publie les résultats financiers du premier semestre 2026 Chiffre d’affaires de 3,5 millions d’euros contre 1,5 million d’euros au premier semestre 2025 Perte nette réduite à 0,5 million d’ [...]
Leads Biolabs Doses First Patient with Systemic Lupus Erythematosus in Phase I Part B Trial of LBL-047, a First-in-Class BDCA2/TACI Bifunctional Fusion Protein
30/10/2026
Dual-Target Approach Designed to Modulate Both Innate and Adaptive Immunity Advances Into Clinical Evaluation in Patients With SLE NANJING, China, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Nanjing Leads Biolabs Co., Ltd. (" [...]
2026 InLight Foundation Stanford Frontier Dialogue: From Nobel Optogenetics to Mind-Light Contemplation, Cross-Disciplinary Experts Explore New Frontiers in Consciousness Regulation
30/10/2026
PALO ALTO, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Following the awarding of the 2026 Nobel Prize in Physiology or Medicine to pioneers in optogenetics, the InLight Foundation concluded its "Consciousness and Science [...]
Aspen Neuroscience Announces Pricing of Initial Public Offering
30/10/2026
SAN DIEGO, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Aspen Neuroscience, Inc. (Nasdaq: ASPE), a clinical-stage regenerative medicine biotechnology company developing autologous cell therapies for Parkinson’s disease (PD), today [...]
InnoCare Announces First Subject Dosed in Clinical Trial of TL1A/IL-23p19 Bispecific Antibody ICP-B161 in China
30/10/2026
BEIJING, Oct. 30, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first [...]
SI-BONE To Present at UBS Global Healthcare Conference on November 10, 2026
29/10/2026
SAN JOSE, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced [...]
Avicanna Announces Closing of Non-Brokered Private Placement of Non-Convertible Debenture Units
29/10/2026
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS TORONTO, Oct. 29 [...]
Seer to Remain an Independent Public Company Following Conclusion of Special Committee Review Process
29/10/2026
REDWOOD CITY, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that the Special Committee of Seer’s Board of [...]
Cytek Biosciences to Participate in Upcoming Investor Conferences
29/10/2026
FREMONT, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the following investor [...]
Tarsus to Report Third Quarter 2026 Financial Results on Tuesday, November 3, 2026
29/10/2026
IRVINE, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that it will host a live webcast at 1:30 p.m. PT / 4:30 p.m. ET on Tuesday, November 3, 2026 to report its [...]
Nephros Schedules Third Quarter 2026 Financial Results Conference Call
29/10/2026
SOUTH ORANGE, N.J., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will [...]
Strom Strategies Calls for a Possible "Black Box Warning" on Al Sayed’s Medicare for All Proposal
29/10/2026
Dr. Joel Strom raises questions about expanding the ACA, patient choice and the need for clear evidence on the plan’s effects. Frisco, TX, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Strom Strategies today called for a detailed [...]
Supernus Announces Third Quarter 2026 Financial Results
29/10/2026
Record total revenues of $226.8 million in the third quarter 2026, an 18% increase compared to same period last year. Combined revenues of the Company's four growth products increased to $192.2 million in the third [...]
Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2027
29/10/2026
Q1 revenue increased by 6% to $1.4 billion; up 7% on a core constant currency basis Q1 GAAP diluted earnings per share up 23% to $2.92; non-GAAP diluted EPS up 14% to $2.91 Returned more than $1.0 billion to [...]
BioStem Technologies to Host Third Quarter 2026 Financial Results Conference Call on November 12, 2026
29/10/2026
Conference call and webcast to be held at 4:30 PM ET POMPANO BEACH, Fla., Oct. 29, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (Nasdaq: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum